In late 2022, Tony and his wife and found out that his father-in-law, Steven, was diagnosed with Parkinson’s Disease (PD). This neurodegenerative disorder afflicts more than 10 million people around the world.

In addition to becoming a Care Advocate to support Steven and the rest of the family through the start of their Parkinson’s journey, Tony also focused on exploring how to accelerate change to improve overall health outcomes for all patients suffering from Parkinsonian symptoms.

To achieve this goal, he is focused on 3 objectives:

1. Patient education: In Asia, how can localised and literacy-relevant content be provided to anyone with Parkinson’s or other Neurodegenerative disorders?
2. Clinical research & infrastructure: How can current global studies such as GP2 have greater participation in Asia?   And how can tech innovations improve infrastructure needed to conduct this research, including the creation of Parkinson’s registries?
3. Public, Private, and Philanthropic Funding: Where can new Asia-based donors,  strategic partners, and health systems direct financial resources in Neurodegenerative research and care to improve outcomes?

For patient education, Tony is starting a new non-profit focused on Asia.

From 2021-2023, Tony contributed to two different healthcare non-fiction books.

In 2021, Tony authored a feature on innovation and partnerships published in The Future of Health.  How Digital Technology will make care accessible, sustainable, and human by Roberto Ascione.  The book was published in Nov 2021 by Wiley.

In 2023, Tony contributed my point of view on health equity and trends for digital medicine to the authors of Medicine without Meds. Transforming Patient Care with Digital Therapies by Dean Ho, Yoann Sapanel, and Agata Blasiak.  The book was published in Oct 2023 by Johns Hopkins Press.

Click below to listen to Episode 1 of this podcast series launched in 2021 to highlight the impact of innovation on public health and private industry as health care programmes shift to having a greater emphasis on prevention and personalised treatments.

Hosted by Tony Estrella, built by FutureProofing Healthcare, and Produced by Mission Based Media and Taliossa, this series explores the foundation of personalised health including its promise, challenges, and potential impact on individuals, providers, private industry, and public health.  Guest include Dr. Rifat Atun (Harvard), Dr. John Sargent (BroadReach), Dr. Joanne Hackett (IQVIA), Dr. Rhoda Au (Boston University), and Janice Chia (Ageing Asia)

Click below to listen to this podcast series launched in 2021 and hear Tony interview prominent business leaders, entrepreneurs, investors, clinicians, and academics from across Asia Pacific on topics including AI, Big Data, Public-Private Partnerships, Venture Investing, and Patient Advocacy.

This series explores the diverse set of health care needs for individuals in a region of 4.5 billion people from over 40 countries.  Hosted and Produced by Tony Estrella along with Mission Based Media, the series features guests from companies including Roche, Verge HealthTech Fund, Precision Public Health Asia Society, Qure.AI, Novartis, Health Catalyst, Holmusk, AXA, UnderwriteMe, WeDoctor, HaloDoc, and AMILI.

This white paper was supported by FutureProofing Healthcare, a global organisation empowering policymakers, healthcare executives, and innovation leaders to transform healthcare into a system supporting personalised healthcare and dynamic prevention.

Tony serves as both a HealthTech expert on an exclusive Advisory Panel and is the author of this recently released narrative envisioning an optimistic outlook for Asia Pacific in 2050.   This paper describes a path where after COVID-19, world leaders eventually come together to bring the benefits of a miracle longevity solution to people everywhere.

As featured in the BBC, Comatose is a globe-trotting thriller that explores the science of the mind.   

First published in 2019 in the UK, the book continues to receive positive affirmations from readers due to its engaging plot, rich character development, and its creative exploration of lucid dreaming.   The novel establishes a link between this unique type of dreaming with comas, triggering a race for survival across the four primary characters and ultimately explaining why we dream.

For 25 years, Tony has generated market impact and produced results for startups to multi-national corporations.  His experience cuts across business functions and stage of company growth including being a serial entrepreneur, leading health innovation within a global insurer, and supporting venture investors to identify new investment opportunities.

Today, Tony is engaged with numerous companies driving disruptive change in health, primarily in Asia Pacific.   Establishing trust with founders, leadership teams, and investors is a core tenet of his approach.   His passion is to help these companies and investors bring a vision of a better health system to life with sustainable products and services.